0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vivo Biosafety Testing Services Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-27L14412
Home | Market Reports | Health| Nursing
Global In Vivo Biosafety Testing Services Market Research Report 2023
BUY CHAPTERS

Global In Vivo Biosafety Testing Services Market Research Report 2024

Code: QYRE-Auto-27L14412
Report
October 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vivo Biosafety Testing Services Market

The global In Vivo Biosafety Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for In Vivo Biosafety Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vivo Biosafety Testing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of In Vivo Biosafety Testing Services include Toyobo Co. Ltd, Charles River Laboratories Inc., Lonza Group, Avance Biosciences Inc., BSL BIOSERVICE Scientific Laboratories Munich GmbH, SGS S.A., Toxikon Corporation, Sartorius Stedim BioOutsource Ltd. and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo Biosafety Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Biosafety Testing Services.

Report Scope

The In Vivo Biosafety Testing Services market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vivo Biosafety Testing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo Biosafety Testing Services manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In Vivo Biosafety Testing Services Market Report

Report Metric Details
Report Name In Vivo Biosafety Testing Services Market
Segment by Type
  • Antibody Production Experiment
  • Exogenous Factor Detection
  • Biological Product Safety Testing
  • Tumorigenicity Detection
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Toyobo Co. Ltd, Charles River Laboratories Inc., Lonza Group, Avance Biosciences Inc., BSL BIOSERVICE Scientific Laboratories Munich GmbH, SGS S.A., Toxikon Corporation, Sartorius Stedim BioOutsource Ltd., Merck KGaA, WuXi Biologics, Shenzhen Hepalink Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of In Vivo Biosafety Testing Services manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of In Vivo Biosafety Testing Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the In Vivo Biosafety Testing Services Market report?

Ans: The main players in the In Vivo Biosafety Testing Services Market are Toyobo Co. Ltd, Charles River Laboratories Inc., Lonza Group, Avance Biosciences Inc., BSL BIOSERVICE Scientific Laboratories Munich GmbH, SGS S.A., Toxikon Corporation, Sartorius Stedim BioOutsource Ltd., Merck KGaA, WuXi Biologics, Shenzhen Hepalink Pharmaceutical Co., Ltd

What are the Application segmentation covered in the In Vivo Biosafety Testing Services Market report?

Ans: The Applications covered in the In Vivo Biosafety Testing Services Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the In Vivo Biosafety Testing Services Market report?

Ans: The Types covered in the In Vivo Biosafety Testing Services Market report are Antibody Production Experiment, Exogenous Factor Detection, Biological Product Safety Testing, Tumorigenicity Detection

1 In Vivo Biosafety Testing Services Market Overview
1.1 Product Overview and Scope of In Vivo Biosafety Testing Services
1.2 In Vivo Biosafety Testing Services Segment by Type
1.2.1 Global In Vivo Biosafety Testing Services Market Value Comparison by Type (2024-2030)
1.2.2 Antibody Production Experiment
1.2.3 Exogenous Factor Detection
1.2.4 Biological Product Safety Testing
1.2.5 Tumorigenicity Detection
1.3 In Vivo Biosafety Testing Services Segment by Application
1.3.1 Global In Vivo Biosafety Testing Services Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global In Vivo Biosafety Testing Services Market Size Estimates and Forecasts
1.4.1 Global In Vivo Biosafety Testing Services Revenue 2019-2030
1.4.2 Global In Vivo Biosafety Testing Services Sales 2019-2030
1.4.3 Global In Vivo Biosafety Testing Services Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 In Vivo Biosafety Testing Services Market Competition by Manufacturers
2.1 Global In Vivo Biosafety Testing Services Sales Market Share by Manufacturers (2019-2024)
2.2 Global In Vivo Biosafety Testing Services Revenue Market Share by Manufacturers (2019-2024)
2.3 Global In Vivo Biosafety Testing Services Average Price by Manufacturers (2019-2024)
2.4 Global In Vivo Biosafety Testing Services Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of In Vivo Biosafety Testing Services, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of In Vivo Biosafety Testing Services, Product Type & Application
2.7 In Vivo Biosafety Testing Services Market Competitive Situation and Trends
2.7.1 In Vivo Biosafety Testing Services Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest In Vivo Biosafety Testing Services Players Market Share by Revenue
2.7.3 Global In Vivo Biosafety Testing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 In Vivo Biosafety Testing Services Retrospective Market Scenario by Region
3.1 Global In Vivo Biosafety Testing Services Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global In Vivo Biosafety Testing Services Global In Vivo Biosafety Testing Services Sales by Region: 2019-2030
3.2.1 Global In Vivo Biosafety Testing Services Sales by Region: 2019-2024
3.2.2 Global In Vivo Biosafety Testing Services Sales by Region: 2025-2030
3.3 Global In Vivo Biosafety Testing Services Global In Vivo Biosafety Testing Services Revenue by Region: 2019-2030
3.3.1 Global In Vivo Biosafety Testing Services Revenue by Region: 2019-2024
3.3.2 Global In Vivo Biosafety Testing Services Revenue by Region: 2025-2030
3.4 North America In Vivo Biosafety Testing Services Market Facts & Figures by Country
3.4.1 North America In Vivo Biosafety Testing Services Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America In Vivo Biosafety Testing Services Sales by Country (2019-2030)
3.4.3 North America In Vivo Biosafety Testing Services Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe In Vivo Biosafety Testing Services Market Facts & Figures by Country
3.5.1 Europe In Vivo Biosafety Testing Services Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe In Vivo Biosafety Testing Services Sales by Country (2019-2030)
3.5.3 Europe In Vivo Biosafety Testing Services Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific In Vivo Biosafety Testing Services Market Facts & Figures by Country
3.6.1 Asia Pacific In Vivo Biosafety Testing Services Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific In Vivo Biosafety Testing Services Sales by Country (2019-2030)
3.6.3 Asia Pacific In Vivo Biosafety Testing Services Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America In Vivo Biosafety Testing Services Market Facts & Figures by Country
3.7.1 Latin America In Vivo Biosafety Testing Services Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America In Vivo Biosafety Testing Services Sales by Country (2019-2030)
3.7.3 Latin America In Vivo Biosafety Testing Services Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa In Vivo Biosafety Testing Services Market Facts & Figures by Country
3.8.1 Middle East and Africa In Vivo Biosafety Testing Services Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa In Vivo Biosafety Testing Services Sales by Country (2019-2030)
3.8.3 Middle East and Africa In Vivo Biosafety Testing Services Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global In Vivo Biosafety Testing Services Sales by Type (2019-2030)
4.1.1 Global In Vivo Biosafety Testing Services Sales by Type (2019-2024)
4.1.2 Global In Vivo Biosafety Testing Services Sales by Type (2025-2030)
4.1.3 Global In Vivo Biosafety Testing Services Sales Market Share by Type (2019-2030)
4.2 Global In Vivo Biosafety Testing Services Revenue by Type (2019-2030)
4.2.1 Global In Vivo Biosafety Testing Services Revenue by Type (2019-2024)
4.2.2 Global In Vivo Biosafety Testing Services Revenue by Type (2025-2030)
4.2.3 Global In Vivo Biosafety Testing Services Revenue Market Share by Type (2019-2030)
4.3 Global In Vivo Biosafety Testing Services Price by Type (2019-2030)
5 Segment by Application
5.1 Global In Vivo Biosafety Testing Services Sales by Application (2019-2030)
5.1.1 Global In Vivo Biosafety Testing Services Sales by Application (2019-2024)
5.1.2 Global In Vivo Biosafety Testing Services Sales by Application (2025-2030)
5.1.3 Global In Vivo Biosafety Testing Services Sales Market Share by Application (2019-2030)
5.2 Global In Vivo Biosafety Testing Services Revenue by Application (2019-2030)
5.2.1 Global In Vivo Biosafety Testing Services Revenue by Application (2019-2024)
5.2.2 Global In Vivo Biosafety Testing Services Revenue by Application (2025-2030)
5.2.3 Global In Vivo Biosafety Testing Services Revenue Market Share by Application (2019-2030)
5.3 Global In Vivo Biosafety Testing Services Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Toyobo Co. Ltd
6.1.1 Toyobo Co. Ltd Corporation Information
6.1.2 Toyobo Co. Ltd Description and Business Overview
6.1.3 Toyobo Co. Ltd In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Toyobo Co. Ltd In Vivo Biosafety Testing Services Product Portfolio
6.1.5 Toyobo Co. Ltd Recent Developments/Updates
6.2 Charles River Laboratories Inc.
6.2.1 Charles River Laboratories Inc. Corporation Information
6.2.2 Charles River Laboratories Inc. Description and Business Overview
6.2.3 Charles River Laboratories Inc. In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Charles River Laboratories Inc. In Vivo Biosafety Testing Services Product Portfolio
6.2.5 Charles River Laboratories Inc. Recent Developments/Updates
6.3 Lonza Group
6.3.1 Lonza Group Corporation Information
6.3.2 Lonza Group Description and Business Overview
6.3.3 Lonza Group In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lonza Group In Vivo Biosafety Testing Services Product Portfolio
6.3.5 Lonza Group Recent Developments/Updates
6.4 Avance Biosciences Inc.
6.4.1 Avance Biosciences Inc. Corporation Information
6.4.2 Avance Biosciences Inc. Description and Business Overview
6.4.3 Avance Biosciences Inc. In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Avance Biosciences Inc. In Vivo Biosafety Testing Services Product Portfolio
6.4.5 Avance Biosciences Inc. Recent Developments/Updates
6.5 BSL BIOSERVICE Scientific Laboratories Munich GmbH
6.5.1 BSL BIOSERVICE Scientific Laboratories Munich GmbH Corporation Information
6.5.2 BSL BIOSERVICE Scientific Laboratories Munich GmbH Description and Business Overview
6.5.3 BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Product Portfolio
6.5.5 BSL BIOSERVICE Scientific Laboratories Munich GmbH Recent Developments/Updates
6.6 SGS S.A.
6.6.1 SGS S.A. Corporation Information
6.6.2 SGS S.A. Description and Business Overview
6.6.3 SGS S.A. In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SGS S.A. In Vivo Biosafety Testing Services Product Portfolio
6.6.5 SGS S.A. Recent Developments/Updates
6.7 Toxikon Corporation
6.6.1 Toxikon Corporation Corporation Information
6.6.2 Toxikon Corporation Description and Business Overview
6.6.3 Toxikon Corporation In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Toxikon Corporation In Vivo Biosafety Testing Services Product Portfolio
6.7.5 Toxikon Corporation Recent Developments/Updates
6.8 Sartorius Stedim BioOutsource Ltd.
6.8.1 Sartorius Stedim BioOutsource Ltd. Corporation Information
6.8.2 Sartorius Stedim BioOutsource Ltd. Description and Business Overview
6.8.3 Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Product Portfolio
6.8.5 Sartorius Stedim BioOutsource Ltd. Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Corporation Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck KGaA In Vivo Biosafety Testing Services Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 WuXi Biologics
6.10.1 WuXi Biologics Corporation Information
6.10.2 WuXi Biologics Description and Business Overview
6.10.3 WuXi Biologics In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.10.4 WuXi Biologics In Vivo Biosafety Testing Services Product Portfolio
6.10.5 WuXi Biologics Recent Developments/Updates
6.11 Shenzhen Hepalink Pharmaceutical Co., Ltd
6.11.1 Shenzhen Hepalink Pharmaceutical Co., Ltd Corporation Information
6.11.2 Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Description and Business Overview
6.11.3 Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Product Portfolio
6.11.5 Shenzhen Hepalink Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 In Vivo Biosafety Testing Services Industry Chain Analysis
7.2 In Vivo Biosafety Testing Services Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 In Vivo Biosafety Testing Services Production Mode & Process
7.4 In Vivo Biosafety Testing Services Sales and Marketing
7.4.1 In Vivo Biosafety Testing Services Sales Channels
7.4.2 In Vivo Biosafety Testing Services Distributors
7.5 In Vivo Biosafety Testing Services Customers
8 In Vivo Biosafety Testing Services Market Dynamics
8.1 In Vivo Biosafety Testing Services Industry Trends
8.2 In Vivo Biosafety Testing Services Market Drivers
8.3 In Vivo Biosafety Testing Services Market Challenges
8.4 In Vivo Biosafety Testing Services Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global In Vivo Biosafety Testing Services Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global In Vivo Biosafety Testing Services Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global In Vivo Biosafety Testing Services Market Competitive Situation by Manufacturers in 2023
    Table 4. Global In Vivo Biosafety Testing Services Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global In Vivo Biosafety Testing Services Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global In Vivo Biosafety Testing Services Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market In Vivo Biosafety Testing Services Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of In Vivo Biosafety Testing Services, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of In Vivo Biosafety Testing Services, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of In Vivo Biosafety Testing Services, Product Type & Application
    Table 12. Global Key Manufacturers of In Vivo Biosafety Testing Services, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global In Vivo Biosafety Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo Biosafety Testing Services as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global In Vivo Biosafety Testing Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global In Vivo Biosafety Testing Services Sales by Region (2019-2024) & (K Units)
    Table 18. Global In Vivo Biosafety Testing Services Sales Market Share by Region (2019-2024)
    Table 19. Global In Vivo Biosafety Testing Services Sales by Region (2025-2030) & (K Units)
    Table 20. Global In Vivo Biosafety Testing Services Sales Market Share by Region (2025-2030)
    Table 21. Global In Vivo Biosafety Testing Services Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global In Vivo Biosafety Testing Services Revenue Market Share by Region (2019-2024)
    Table 23. Global In Vivo Biosafety Testing Services Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global In Vivo Biosafety Testing Services Revenue Market Share by Region (2025-2030)
    Table 25. North America In Vivo Biosafety Testing Services Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America In Vivo Biosafety Testing Services Sales by Country (2019-2024) & (K Units)
    Table 27. North America In Vivo Biosafety Testing Services Sales by Country (2025-2030) & (K Units)
    Table 28. North America In Vivo Biosafety Testing Services Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America In Vivo Biosafety Testing Services Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe In Vivo Biosafety Testing Services Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe In Vivo Biosafety Testing Services Sales by Country (2019-2024) & (K Units)
    Table 32. Europe In Vivo Biosafety Testing Services Sales by Country (2025-2030) & (K Units)
    Table 33. Europe In Vivo Biosafety Testing Services Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe In Vivo Biosafety Testing Services Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific In Vivo Biosafety Testing Services Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific In Vivo Biosafety Testing Services Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific In Vivo Biosafety Testing Services Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America In Vivo Biosafety Testing Services Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America In Vivo Biosafety Testing Services Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America In Vivo Biosafety Testing Services Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America In Vivo Biosafety Testing Services Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America In Vivo Biosafety Testing Services Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa In Vivo Biosafety Testing Services Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa In Vivo Biosafety Testing Services Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa In Vivo Biosafety Testing Services Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global In Vivo Biosafety Testing Services Sales (K Units) by Type (2019-2024)
    Table 51. Global In Vivo Biosafety Testing Services Sales (K Units) by Type (2025-2030)
    Table 52. Global In Vivo Biosafety Testing Services Sales Market Share by Type (2019-2024)
    Table 53. Global In Vivo Biosafety Testing Services Sales Market Share by Type (2025-2030)
    Table 54. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global In Vivo Biosafety Testing Services Revenue Market Share by Type (2019-2024)
    Table 57. Global In Vivo Biosafety Testing Services Revenue Market Share by Type (2025-2030)
    Table 58. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2019-2024)
    Table 59. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2025-2030)
    Table 60. Global In Vivo Biosafety Testing Services Sales (K Units) by Application (2019-2024)
    Table 61. Global In Vivo Biosafety Testing Services Sales (K Units) by Application (2025-2030)
    Table 62. Global In Vivo Biosafety Testing Services Sales Market Share by Application (2019-2024)
    Table 63. Global In Vivo Biosafety Testing Services Sales Market Share by Application (2025-2030)
    Table 64. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global In Vivo Biosafety Testing Services Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global In Vivo Biosafety Testing Services Revenue Market Share by Application (2019-2024)
    Table 67. Global In Vivo Biosafety Testing Services Revenue Market Share by Application (2025-2030)
    Table 68. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2019-2024)
    Table 69. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2025-2030)
    Table 70. Toyobo Co. Ltd Corporation Information
    Table 71. Toyobo Co. Ltd Description and Business Overview
    Table 72. Toyobo Co. Ltd In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Toyobo Co. Ltd In Vivo Biosafety Testing Services Product
    Table 74. Toyobo Co. Ltd Recent Developments/Updates
    Table 75. Charles River Laboratories Inc. Corporation Information
    Table 76. Charles River Laboratories Inc. Description and Business Overview
    Table 77. Charles River Laboratories Inc. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Charles River Laboratories Inc. In Vivo Biosafety Testing Services Product
    Table 79. Charles River Laboratories Inc. Recent Developments/Updates
    Table 80. Lonza Group Corporation Information
    Table 81. Lonza Group Description and Business Overview
    Table 82. Lonza Group In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Lonza Group In Vivo Biosafety Testing Services Product
    Table 84. Lonza Group Recent Developments/Updates
    Table 85. Avance Biosciences Inc. Corporation Information
    Table 86. Avance Biosciences Inc. Description and Business Overview
    Table 87. Avance Biosciences Inc. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Avance Biosciences Inc. In Vivo Biosafety Testing Services Product
    Table 89. Avance Biosciences Inc. Recent Developments/Updates
    Table 90. BSL BIOSERVICE Scientific Laboratories Munich GmbH Corporation Information
    Table 91. BSL BIOSERVICE Scientific Laboratories Munich GmbH Description and Business Overview
    Table 92. BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. BSL BIOSERVICE Scientific Laboratories Munich GmbH In Vivo Biosafety Testing Services Product
    Table 94. BSL BIOSERVICE Scientific Laboratories Munich GmbH Recent Developments/Updates
    Table 95. SGS S.A. Corporation Information
    Table 96. SGS S.A. Description and Business Overview
    Table 97. SGS S.A. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. SGS S.A. In Vivo Biosafety Testing Services Product
    Table 99. SGS S.A. Recent Developments/Updates
    Table 100. Toxikon Corporation Corporation Information
    Table 101. Toxikon Corporation Description and Business Overview
    Table 102. Toxikon Corporation In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Toxikon Corporation In Vivo Biosafety Testing Services Product
    Table 104. Toxikon Corporation Recent Developments/Updates
    Table 105. Sartorius Stedim BioOutsource Ltd. Corporation Information
    Table 106. Sartorius Stedim BioOutsource Ltd. Description and Business Overview
    Table 107. Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Sartorius Stedim BioOutsource Ltd. In Vivo Biosafety Testing Services Product
    Table 109. Sartorius Stedim BioOutsource Ltd. Recent Developments/Updates
    Table 110. Merck KGaA Corporation Information
    Table 111. Merck KGaA Description and Business Overview
    Table 112. Merck KGaA In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Merck KGaA In Vivo Biosafety Testing Services Product
    Table 114. Merck KGaA Recent Developments/Updates
    Table 115. WuXi Biologics Corporation Information
    Table 116. WuXi Biologics Description and Business Overview
    Table 117. WuXi Biologics In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. WuXi Biologics In Vivo Biosafety Testing Services Product
    Table 119. WuXi Biologics Recent Developments/Updates
    Table 120. Shenzhen Hepalink Pharmaceutical Co., Ltd Corporation Information
    Table 121. Shenzhen Hepalink Pharmaceutical Co., Ltd Description and Business Overview
    Table 122. Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Shenzhen Hepalink Pharmaceutical Co., Ltd In Vivo Biosafety Testing Services Product
    Table 124. Shenzhen Hepalink Pharmaceutical Co., Ltd Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. In Vivo Biosafety Testing Services Distributors List
    Table 128. In Vivo Biosafety Testing Services Customers List
    Table 129. In Vivo Biosafety Testing Services Market Trends
    Table 130. In Vivo Biosafety Testing Services Market Drivers
    Table 131. In Vivo Biosafety Testing Services Market Challenges
    Table 132. In Vivo Biosafety Testing Services Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of In Vivo Biosafety Testing Services
    Figure 2. Global In Vivo Biosafety Testing Services Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global In Vivo Biosafety Testing Services Market Share by Type in 2023 & 2030
    Figure 4. Antibody Production Experiment Product Picture
    Figure 5. Exogenous Factor Detection Product Picture
    Figure 6. Biological Product Safety Testing Product Picture
    Figure 7. Tumorigenicity Detection Product Picture
    Figure 8. Global In Vivo Biosafety Testing Services Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global In Vivo Biosafety Testing Services Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global In Vivo Biosafety Testing Services Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global In Vivo Biosafety Testing Services Market Size (2019-2030) & (US$ Million)
    Figure 15. Global In Vivo Biosafety Testing Services Sales (2019-2030) & (K Units)
    Figure 16. Global In Vivo Biosafety Testing Services Average Price (US$/Unit) & (2019-2030)
    Figure 17. In Vivo Biosafety Testing Services Report Years Considered
    Figure 18. In Vivo Biosafety Testing Services Sales Share by Manufacturers in 2023
    Figure 19. Global In Vivo Biosafety Testing Services Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest In Vivo Biosafety Testing Services Players: Market Share by Revenue in 2023
    Figure 21. In Vivo Biosafety Testing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global In Vivo Biosafety Testing Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America In Vivo Biosafety Testing Services Sales Market Share by Country (2019-2030)
    Figure 24. North America In Vivo Biosafety Testing Services Revenue Market Share by Country (2019-2030)
    Figure 25. United States In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe In Vivo Biosafety Testing Services Sales Market Share by Country (2019-2030)
    Figure 28. Europe In Vivo Biosafety Testing Services Revenue Market Share by Country (2019-2030)
    Figure 29. Germany In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific In Vivo Biosafety Testing Services Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific In Vivo Biosafety Testing Services Revenue Market Share by Region (2019-2030)
    Figure 36. China In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America In Vivo Biosafety Testing Services Sales Market Share by Country (2019-2030)
    Figure 44. Latin America In Vivo Biosafety Testing Services Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa In Vivo Biosafety Testing Services Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa In Vivo Biosafety Testing Services Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE In Vivo Biosafety Testing Services Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of In Vivo Biosafety Testing Services by Type (2019-2030)
    Figure 54. Global Revenue Market Share of In Vivo Biosafety Testing Services by Type (2019-2030)
    Figure 55. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of In Vivo Biosafety Testing Services by Application (2019-2030)
    Figure 57. Global Revenue Market Share of In Vivo Biosafety Testing Services by Application (2019-2030)
    Figure 58. Global In Vivo Biosafety Testing Services Price (US$/Unit) by Application (2019-2030)
    Figure 59. In Vivo Biosafety Testing Services Value Chain
    Figure 60. In Vivo Biosafety Testing Services Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Body Fluid Collection And Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18U13002
Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Triple X Syndrome Management - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19Q13375
Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global In Vivo Biosafety Testing Services Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27L14412
Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global 3D Computed Tomography Software Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9O10905
Thu Oct 03 00:00:00 UTC 2024

Add to Cart